Clinical Trials of Tavegyl in Dermatologic Field / 대한피부과학회지
Korean Journal of Dermatology
; : 33-37, 1974.
Article
in Korean
| WPRIM (Western Pacific)
| ID: wpr-219376
Responsible library:
WPRO
ABSTRACT
Clinical trials were done to obtain ifnormation on the clinical efficacy, tolerance and side effects of a new antihistarnine, Mecloprodine(Tavegyl), in various skin disordetrs. A total of 48 patients suffered from various skin disorders as urticaria, eczema etc. v ere treated with 2mg. daily for 3 days to 15 days according to state of disorders. The results are as follows. 1. Improvement was noticed in 79.2% of total patients(38/48). 2. Tavegyl was efiective in all 8 cases of acute urticaria and most cases(7/8) of urticaria factitia. 3. Among 19 cases of chronic urticaria, improvement was noticed in 13 cases(68. 49). Improvement was alsa noticed in all 6 cases of eczema. 5. Drowsiness and weakness cccurred in 6.2% of cases(3/48).
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Skin
/
Sleep Stages
/
Urticaria
/
Clemastine
/
Eczema
Limits:
Humans
Language:
Korean
Journal:
Korean Journal of Dermatology
Year:
1974
Document type:
Article